Biologist Brett Weinstein shared his views with Tucker Carlson on Wednesday, suggesting that the decision to keep the Covid-19 vaccine on the U.S. vaccination schedule might be influenced by the White House.
In February 2023, the CDC revealed plans to include the Covid-19 vaccine in its schedule for children, teens, and adults. During an appearance on “The Tucker Carlson Show,” Carlson quizzed Weinstein about the ongoing promotion of the CDC’s Covid-19 shot and questioned whether any cabinet member could make independent decisions.
“Can you break this down? It’s pretty convoluted. Is there any cabinet secretary who can act autonomously?” Carlson asked.
Weinstein responded by mentioning Health and Human Services Secretary Bobby Kennedy Jr., implying that if Kennedy had the authority, he might be more forthcoming.
Following up, Carlson wondered if Weinstein thought the White House was indeed the decision-maker. Weinstein replied, “Bobby’s well aware of the issues with these shots—better than most. It certainly feels like a White House call.” He continued, suggesting that each passing month brings more pressure for children to receive these vaccines.
Carlson then posed the question regarding parental decisions, saying, “People are actually asking, ‘Will you give my child a Covid shot?'”
Since the CDC’s recommendation in 2023, the agency continues to advocate for a four-dose Covid-19 vaccine series for children six months and older. Although Kennedy has softened his views on some vaccines, he still openly critiques the CDC’s stance on integrating Covid-19 shots into children’s schedules.
He remarked on the perplexity many first-time parents face when navigating vaccine information, especially when doctors emphasize the necessity of this and other vaccinations. “Most parents don’t even know what questions to ask. The incentives for doctors to ensure children receive all suggested vaccines complicate the situation further,” he said.
Carlson added, “I feel there will be accountability here,” reflecting a belief that answers will be required eventually.
As the Covid-19 vaccine rollout took shape across America, companies like Pfizer experienced significant profits from booster shots and antiviral treatments like Paxlovid, despite concerns about side effects linked to both. In May 2022, Moderna reported nearly $6 billion in vaccine sales for the first quarter, significantly up from 2021. Pfizer’s profits for the same period surged by 61%, reaching $8 billion.
“Honestly, I find it hard to believe that any physician aware of the situation isn’t addressing these truths,” Weinstein remarked.
In February, President Donald Trump signed an executive order aimed at making education more accessible by terminating Covid-19 vaccine mandates in schools, stressing that federal funds cannot be utilized for this purpose.
